With the greater part of third quarter earnings results in the rearview mirror, investors are looking ahead to marquee ...
Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...
Mixed options sentiment in Moderna (MRNA), with shares down 94c near $23.98. Options volume relatively light with 49k contracts traded and calls leading puts for a put/call ratio of 0.47, compared to ...
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...
Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash. Following a series of setbacks for the biotech, ...
With the greater part of third quarter earnings results in the rearview mirror, investors are looking closely at marquee ...
Xiaomi’s EV division makes profit for the first time. Workday to buy AI integration platform Pipedream. Brookfield targets $10B for AI infrastructure fund, investors include Nvidia - report.